CCL2 and COVID-19: In summary, BAL of severe COVID-19 patients are enriched with CCL2, the main chemoattractant of inflammatory monocytes, therefore migration of monocytes to the lungs increases, but these monocytes have decreased HLA-DR expression [16, 40, 41].